Skip to main content
TipRanks
Go Ultimate75% OFF

Elliot Sigal Insider Profile

4 Followers

Elliot Sigal, EVP, CSO & President R&D, Director at Bristol-Myers Squibb, holds 0.00 shares in Spark Therapeutics (Ticker: ONCE), holds 22.62K shares in Mead Johnson (Ticker: MJN), holds 195.30K shares in Bristol-Myers Squibb (Ticker: BMY).

Elliot Sigal's Trading History

ONCE
Spark Therapeutics
Dec 17, 2019―Uninformative Sell1.63M$0.00
MJN
Mead Johnson
Jun 15, 2017―Uninformative Sell2.40M$2.04M
BMY
Bristol-Myers Squibb
Jun 05, 2013EVP, CSO & President R&D, DirectorUninformative Sell4.03M$12.17M

You May Also Like

Elliot Sigal insider profile FAQ

What is the percentage of profitable transactions made by Elliot Sigal?
The percentage of profitable transactions made by Elliot Sigal is 33%.
What is the average return per transaction made by Elliot Sigal?
The average return per transaction made by Elliot Sigal is -0.50%.
What stocks does Elliot Sigal hold?
Elliot Sigal holds: BMY, ONCE, MJN stocks.
What was Elliot Sigal’s latest transaction?
Elliot Sigal’s latest transaction was an Uninformative Sell of $1.63M.
What was Elliot Sigal's most profitable transaction?
Elliot Sigal’s most profitable transaction was an Informative Buy of ONCE stock on April 16, 2018. The return on the trade was 42.40%.
What is Elliot Sigal's role in Bristol-Myers Squibb?
Elliot Sigal's role in Bristol-Myers Squibb is EVP, CSO & President R&D, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.